Literature DB >> 27492117

Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Naveen Pemmaraju1, Vikas Gupta2, Michael A Thompson3, Andrew A Lane4.   

Abstract

The incorporation of Internet resources and the use of social media among patients, clinicians, advocates, and researchers in the field of hematology and oncology are growing in importance. Utilization of online information sharing is rising, especially among those involved in rare blood cancer fields, which have generally featured a paucity of reliable, updated information. In particular, blastic plasmacytoid dendritic cell neoplasm (BPDCN), an uncommon, but highly aggressive hematologic malignancy, is one example of a cancer with limited information readily available to the general public. The infrequent incidence of BPDCN, the challenges in recognizing the disease and making a clinico-pathologic diagnosis, and the lack of standard therapies are some of the reasons accounting for the dearth of expert opinion, scientific publications and discussion, and accessibility of online information for patients. This article highlights social media and Internet sources available for patients and other healthcare stakeholders in the field of BPDCN and discusses our efforts to increase awareness and propagation of BPDCN electronic resources, including the founding of an online Twitter community, #BPDCN.

Entities:  

Keywords:  #BPDCN; BPDCN; Disease-specific hashtag; Rare disease; Social media; Twitter

Mesh:

Year:  2016        PMID: 27492117     DOI: 10.1007/s11899-016-0340-3

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  33 in total

1.  Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

Authors:  Arthur E Frankel; Jung H Woo; Chul Ahn; Naveen Pemmaraju; Bruno C Medeiros; Hetty E Carraway; Olga Frankfurt; Stephen J Forman; Xuezhong A Yang; Marina Konopleva; Francine Garnache-Ottou; Fanny Angelot-Delettre; Christopher Brooks; Michael Szarek; Eric Rowinsky
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

2.  Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Tomohiro Aoki; Ritsuro Suzuki; Yachiyo Kuwatsuka; Shinichi Kako; Katsuya Fujimoto; Jun Taguchi; Tadakazu Kondo; Kinya Ohata; Toshiro Ito; Yoshimasa Kamoda; Takahiro Fukuda; Tatsuo Ichinohe; Kengo Takeuchi; Koji Izutsu; Junji Suzumiya
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

3.  Scientists in the Twitterverse.

Authors:  Neil Savage
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

Review 4.  Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer.

Authors:  Miguel-Angel Perales; Emily K Drake; Naveen Pemmaraju; William A Wood
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

5.  Qualitative Twitter analysis of participants, tweet strategies, and tweet content at a major urologic conference.

Authors:  Hendrik Borgmann; Jan-Henning Woelm; Axel Merseburger; Tim Nestler; Johannes Salem; Maximilian P Brandt; Axel Haferkamp; Stacy Loeb
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

Review 6.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

Review 7.  Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.

Authors:  Mohamed A Kharfan-Dabaja; Hillard M Lazarus; Taiga Nishihori; Rami A Mahfouz; Mehdi Hamadani
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-05       Impact factor: 5.742

Review 8.  Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider.

Authors:  Michael A Thompson; Navneet S Majhail; William A Wood; Miguel-Angel Perales; Mélanie Chaboissier
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

9.  Leveraging Social Media to Promote Public Health Knowledge: Example of Cancer Awareness via Twitter.

Authors:  Songhua Xu; Christopher Markson; Kaitlin L Costello; Cathleen Y Xing; Kitaw Demissie; Adana Am Llanos
Journal:  JMIR Public Health Surveill       Date:  2016-04-28

10.  Twitter Social Media is an Effective Tool for Breast Cancer Patient Education and Support: Patient-Reported Outcomes by Survey.

Authors:  Deanna J Attai; Michael S Cowher; Mohammed Al-Hamadani; Jody M Schoger; Alicia C Staley; Jeffrey Landercasper
Journal:  J Med Internet Res       Date:  2015-07-30       Impact factor: 5.428

View more
  9 in total

Review 1.  Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Michael A Thompson; Andrew A Lane
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

2.  Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends.

Authors:  Naveen Pemmaraju; Michael A Thompson; Ruben A Mesa; Tejas Desai
Journal:  J Oncol Pract       Date:  2017-05-17       Impact factor: 3.840

Review 3.  Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine.

Authors:  Deanna J Attai; Patricia F Anderson; Michael J Fisch; David L Graham; Matthew S Katz; Jennifer Kesselheim; Merry Jennifer Markham; Nathan A Pennell; Mina S Sedrak; Michael A Thompson; Audun Utengen; Don S Dizon
Journal:  Semin Hematol       Date:  2017-08-12       Impact factor: 3.851

Review 4.  The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette.

Authors:  Naveen Pemmaraju; Ruben A Mesa; Navneet S Majhail; Michael A Thompson
Journal:  Semin Hematol       Date:  2017-08-24       Impact factor: 3.851

Review 5.  Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Jean-Jacques Kiladjian; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

Review 6.  Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN-Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Michael A Thompson; Andrew A Lane
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 7.  Online and Social Media Resources for Patients with MDS.

Authors:  Nour Abuhadra; Aziz Nazha
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

8.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

9.  Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience.

Authors:  Siba El Hussein; Joseph D Khoury; Kirill A Lyapichev; Mehrnoosh Tashakori; Mahsa Khanlari; Roberto N Miranda; Rashmi Kanagal-Shamanna; Sa A Wang; Aadil Ahmed; Kamran M Mirza; Genevieve M Crane; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Mod Pathol       Date:  2020-11-20       Impact factor: 7.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.